Lamotrigine

NDC 65162-949 · Amneal Pharmaceuticals LLC

Generic nameLamotrigine

Dosage formTABLET, FILM COATED, EXTENDED RELEASE

RouteORAL

Active ingredient(s)LAMOTRIGINE

Strength25 mg/1

Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]

Marketing categoryANDA

Packages

65162-949-03 — 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-949-03)

65162-949-09 — 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-949-09)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-096 — lamotrigine, 62332-417 — Lamotrigine, 62332-418 — Lamotrigine, 62332-419 — Lamotrigine, 62332-770 — Lamotrigine, 62332-771 — Lamotrigine, 62332-772 — Lamotrigine, 62332-773 — Lamotrigine, 63187-487 — Lamotrigine, 63629-4697 — Lamotrigine, 65162-956 — Lamotrigine, 65162-958 — Lamotrigine, 65162-986 — Lamotrigine, 65162-988 — Lamotrigine, 65162-990 — Lamotrigine, 65841-682 — Lamotrigine, 65841-683 — Lamotrigine, 65841-684 — Lamotrigine, 65841-685 — Lamotrigine, 65841-686 — Lamotrigine, +270 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels